Vimarsana
Biggest News Aggregation in the World

Themis Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Themis Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Themis Bioscience Today - Breaking & Trending Today

Medigene : CV Dr. Gerd Zettlmeissl - MarketScreener - Vimarsana News

Medigene : CV Dr. Gerd Zettlmeissl - MarketScreener

Annual general meeting of Medigene AG on 24 June 2024 Convenience Translation Gerd Zettlmeissl, PhD ...

Eight biotech companies you should know about in Austria - Vimarsana News

Eight biotech companies you should know about in Austria

Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.

AlgoTx Raises €20M to Conduct ATX01's Phase 2 Program in Peripheral Neuropathic Pain - Vimarsana News

AlgoTx Raises €20M to Conduct ATX01's Phase 2 Program in Peripheral Neuropathic Pain

European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), announced today the success of a €20M Series B fundraising led by Relyens

Cancer Vaccines Global Market Report 2023 - Vimarsana News

Cancer Vaccines Global Market Report 2023

Major players in the cancer vaccines market are GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi Pasteur,...

As CEPI ramps up vaccine research, a new study warns Lassa fever is set to expand its reach across Africa - Vimarsana News

As CEPI ramps up vaccine research, a new study warns Lassa fever is set to expand its reach across Africa

Climate change and other environmental factors could cause Lassa fever to spread to additional regions within Africa, new research predicts. CEPI is the leading funder of research into vaccines against the potentially deadly virus.

Source: gavi.org